Probiotic supplementation and late-onset sepsis in preterm infants: A meta-analysis

Pediatrics

Volumn 137, Issue 3, 2016, Pages

  Rao, Shripada C ^a,b   Athalye Jape, Gayatri K ^a,b   Deshpande, Girish C ^c,d   Simmer, Karen N ^a,b   Patole, Sanjay K ^a,b  

^a PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NEPEAN HOSPITAL   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; PROBIOTIC AGENT;

BIFIDOBACTERIUM; DIET SUPPLEMENTATION; HUMAN; INFANT; LACTOBACILLUS; LATE ONSET SEPSIS; META ANALYSIS; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SEPSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; DIETARY SUPPLEMENT; ENTEROCOLITIS, NECROTIZING;

DIETARY SUPPLEMENTS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT; INFANT, PREMATURE; PROBIOTICS; SEPSIS;

EID: 84960156952     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2015-3684     Document Type: Review

References (103)

1. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F257-F263
2. Hossain S, Shah PS, Ye XY, Darlow BA, Lee SK, Lui K; Canadian Neonatal Network; Australian and New Zealand Neonatal Network. Outcome comparison of very preterm infants cared for in the neonatal intensive care units in Australia and New Zealand and in Canada. J Paediatr Child Health. 2015;51(9):881-888
3. Shah J, Jefferies AL, Yoon EW, Lee SK, Shah PS; Canadian Neonatal Network. Risk factors and outcomes of lateonset bacterial sepsis in preterm neonates born at <32 weeks' gestation. Am J Perinatol. 2015;32(7):675-682
4. Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birthweight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012;88(suppl 2):S69-S74
5. Alshaikh B, Yee W, Lodha A, Henderson E, Yusuf K, Sauve R. Coagulase-negative staphylococcus sepsis in preterm infants and longterm neurodevelopmental outcome. J Perinatol. 2014;34(2):125-129
6. van der Ree M, Tanis JC, Van Braeckel KN, Bos AF, Roze E. Functional impairments at school age of preterm born children with late-onset sepsis. Early Hum Dev. 2011;87(12):821-826
7. Strunk T, Inder T, Wang X, Burgner D, Mallard C, Levy O. Infection-induced inflammation and cerebral injury in preterm infants. Lancet Infect Dis. 2014;14(8):751-762
8. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 pt 1):285-291
9. Bizzarro MJ, Shabanova V, Baltimore RS, Dembry LM, Ehrenkranz RA, Gallagher PG. Neonatal sepsis 2004-2013: the rise and fall of coagulasenegative staphylococci. J Pediatr. 2015;166(5):1193-1199
10. Resende DS, Peppe AL, dos Reis H, Abdallah VO, Ribas RM, Gontijo Filho PP. Late onset sepsis in newborn babies: epidemiology and effect of a bundle to prevent central line associated bloodstream infections in the neonatal intensive care unit. Braz J Infect Dis. 2015;19(1):52-57
11. Al-Taiar A, Hammoud MS, Cuiqing L, et al. Neonatal infections in China, Malaysia, Hong Kong and Thailand. Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F249-F255
12. Tran HT, Doyle LW, Lee KJ, Dang NM, Graham SM. A high burden of late-onset sepsis among newborns admitted to the largest neonatal unit in central Vietnam. J Perinatol. 2015;35:846-851
13. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365(9465):1175-1188
14. Muley VA, Ghadage DP, Bhore AV. Bacteriological profile of neonatal septicemia in a tertiary care hospital from Western India. J Glob Infect Dis. 2015;7(2):75-77
15. Ramasamy S, Biswal N, Bethou A, Mathai B. Comparison of two empiric antibiotic regimen in late onset neonatal sepsis: a randomized controlled trial. J Trop Pediatr. 2014;60(1):83-86
16. Basu S. Neonatal sepsis: the gut connection. Eur J Clin Microbiol Infect Dis. 2015;34(2):215-222
17. Lona Reyes JC, Verdugo Robles MA, Pérez Ramírez RO, Pérez Molina JJ, Ascencio Esparza EP, Benítez Vázquez EA. Etiology and antimicrobial resistance patterns in early and late neonatal sepsis in a neonatal intensive care unit. Arch Argent Pediatr. 2015;113(4):317-323
18. Shane AL, Stoll BJ. Neonatal sepsis: progress towards improved outcomes. J Infect. 2014;68(suppl 1):S24-S32
19. Janota J, Sebkova S, Visnovska M, Kudlackova J, Hamplova D, Zach J. Hand hygiene with alcohol hand rub and gloves reduces the incidence of late onset sepsis in preterm neonates. Acta Paediatr. 2014;103(10):1053-1056
20. Lean WL, Kamlin CO, Garland SM, Jacobs SE. Stable rates of neonatal sepsis in a tertiary neonatal unit. J Paediatr Child Health. 2015;51(3):294-299
21. Molyneux E, Gest A. Neonatal sepsis: an old issue needing new answers. Lancet Infect Dis. 2015;15(5):503-505
22. Strunk T, Kollmann T, Patole S. Probiotics to prevent earlylife infection. Lancet Infect Dis. 2015;15(4):378-379
23. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514
24. Crooks NH, Snaith C, Webster D, Gao F, Hawkey P. Clinical review: probiotics in critical care. Crit Care. 2012;16(6):237
25. Rao RK, Samak G. Protection and restitution of gut barrier by probiotics: nutritional and clinical implications. Curr Nutr Food Sci. 2013;9(2):99-107
26. Ewaschuk JB, Diaz H, Meddings L, et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol. 2008;295(5):G1025-G1034
27. Sassone-Corsi M, Raffatellu M. No vacancy: how beneficial microbes cooperate with immunity to provide colonization resistance to pathogens. J Immunol. 2015;194(9):4081-4087
28. Hammerman C, Kaplan M. Probiotics and neonatal intestinal infection. Curr Opin Infect Dis. 2006;19(3):277-282
29. Garrido D, Barile D, Mills DA. A molecular basis for bifidobacterial enrichment in the infant gastrointestinal tract. Adv Nutr. 2012;3(3):415S-421S
30. Fukuda S, Toh H, Hase K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature. 2011;469(7331):543-547
31. Walker A. Intestinal colonization and programming of the intestinal immune response. J Clin Gastroenterol. 2014;48(suppl 1):S8-S11
32. Al-Nedawi K, Mian MF, Hossain N, et al Gut commensal microvesicles reproduce parent bacterial signals to host immune and enteric nervous systems. FASEBJ. 2015;29(2):684-695
33. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. 2014;4:CD005496
34. Lau CS, Chamberlain RS. Probiotic administration can prevent necrotizing enterocolitis in preterm infants: a meta-analysis. J Pediatr Surg. 2015;50(8):1405-1412
35. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). London, England: The Cochrane Collaboration; 2011. Available at: www.cochrane-handbook.org
36. Moher D, Altman DG, Liberati A, Tetzlaff J. PRISMA statement. Epidemiology. 2011;22(1):128, author reply 128
37. Yang Y, Guo Y, Kan Q, Zhou XG, Zhou XY, Li Y. A meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Braz J Med Biol Res. 2014;47(9):804-810
38. Wang Q, Dong J, Zhu Y. Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birth-weight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg. 2012;47(1):241-248
39. Sterne JA, Egger M. Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol. 2001;54(10):1046-1055
40. Egger M, Ebrahim S, Smith GD. Where now for meta-analysis? Int J Epidemiol. 2002;31(1):1-5
41. Unger S, Stintzi A, Shah P, Mack D, O'Connor DL. Gut microbiota of the very-low-birth-weight infant. Pediatr Res. 2015;77(1-2):205-213
42. Chapman CM, Gibson GR, Rowland I. Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr. 2011;50(1):1-17
43. Guyatt GH, Oxman AD, Santesso N, et al. GRADE guidelines: 12. Preparing summary of findings tables-binary outcomes. J Clin Epidemiol. 2013;66(2):158-172
44. Al-Hosni M, Duenas M, Hawk M, et al Probiotics-supplemented feeding in extremely low-birth weight infants. J Perinatol. 2012;32(4):253-259
45. Awad H, Mokhtar H, Imam SS, Gad GI, Hafez H, Aboushady N. Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci. 2010;13(6):253-262
46. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147(2):192-196
47. Braga TD, da Silva GA, de Lira PI, de Carvalho Lima M. Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial. Am J Clin Nutr. 2011;93(1):81-86
48. Chrzanowska-Liszewska D, Seliga-Siwecka J, Kornacka MK. The effect of Lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infantsdouble blinded randomized control trial. Early Hum Dev. 2012;88(1):57-60
49. Costalos C, Skouteri V, Gounaris A, et al. Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev. 2003;74(2):89-96
50. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate. 2002;82(2):103-108
51. Demirel G, Erdeve O, Celik IH, Dilmen U. Saccharomyces boulardii for prevention of necrotizing enterocolitis in preterm infants: a randomized, controlled study. Acta Paediatr. 2013;102(12). Available at: www.pediatrics.org/cgi/content/full/102/12/e560
52. Dilli D, Aydin B, Fettah ND, et al. The propre-save study: effects of probiotics and prebiotics alone or combined on necrotizing enterocolitis in very low birth weight infants. J Pediatr. 2015;166(3):545-51.e1
53. Dutta S, Ray P, Narang A. Comparison of stool colonization in premature infants by three dose regimes of a probiotic combination: a randomized controlled trial. Am J Perinatol. 2015;32(8):733-740
54. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, et al. Doubleblind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F5-F9
55. Hays S, Jacquot A, Gauthier H, et al. Probiotics and growth in preterm infants: a randomized controlled trial, PREMAPRO study. Clin Nutr. 2015. 10.1016/j.clnu.2015.06.006
56. Hikaru U, Koichi S, Yayoi S, et al. Bifidobacteria prevents preterm infants from developing infection and sepsis. Int J Probiotics Prebiotics. 2010;5(1):33-36
57. Hua XT, Tang J, Mu DZ. [Effect of oral administration of probiotics on intestinal colonization with drugresistant bacteria in preterm infants]. Zhongguo Dang Dai Er Ke Za Zhi. 2014;16(6):606-609
58. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M. Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 1997;76(2):F101-F107
59. Lin HC, Su BH, Chen AC, et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics. 2005;115(1):1-4
60. Lin HC, Hsu CH, Chen HL, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693-700
61. Manzoni P, Mostert M, Leonessa ML, et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis. 2006;42(12):1735-1742
62. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F. Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-lowbirthweight infants: a randomized controlled trial. Neonatology. 2010;98(2):156-163
63. Millar MR, Bacon C, Smith SL, Walker V, Hall MA. Enteral feeding of premature infants with Lactobacillus GG. Arch Dis Child. 1993;69(5 spec no):483-487
64. Oncel MY, Sari FN, Arayici S, et al. Lactobacillus reuteri for the prevention of necrotising enterocolitis in very low birthweight infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2014;99(2):F110-F115
65. Partty A, Luoto R, Kalliomaki M, Salminen S, Isolauri E. Effects of early prebiotic and probiotic supplementation on development of gut microbiota and fussing and crying in preterm infants: a randomized, double-blind, placebo-controlled trial. J Pediatr. 2013;163(5):1272-1277. e1271-1272
66. Patole S, Keil AD, Chang A, et al. Effect of Bifidobacterium breve M-16V supplementation on fecal bifidobacteria in preterm neonates: a randomised double blind placebo controlled trial. PLoS One. 2014;9(3):e89511
67. Costeloe K, Wilks M, Hardy P, Nelis C, Millar M. O-008 early Bifidobacterium breve Bbg-001 to prevent necrotising enterocolitis, late-onset sepsis and death: the PiPS Trial. Arch Dis Child. 2014;99(suppl 2):A23-A24
68. Jacobs SE, Tobin JM, Opie GF, et al; ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055-1062
69. Rojas MA, Lozano JM, Rojas MX, et al. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics. 2012;130(5). Available at: www.pediatrics.org/cgi/content/full/130/5/e1113
70. Romeo MG, Romeo DM, Trovato L, et al Role of probiotics in the prevention of the enteric colonization by Candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol. 2011;31(1):63-69
71. Rougé C, Piloquet H, Butel MJ, et al. Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2009;89(6):1828-1835
72. Roy A, Chaudhuri J, Sarkar D, Ghosh P, Chakraborty S. Role of enteric supplementation of probiotics on late-onset sepsis by Candida species in preterm low birth weight neonates: a randomized, double blind, placebocontrolled trial. N Am J Med Sci. 2014;6(1):50-57
73. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr. 2009;55(2):128-131
74. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr. 2011;65(4):434-439
75. Serce O, Benzer D, Gursoy T, Karatekin G, Ovali F. Efficacy of Saccharomyces boulardii on necrotizing enterocolitis or sepsis in very low birth weight infants: a randomised controlled trial. Early Hum Dev. 2013;89(12):1033-1036
76. Stratiki Z, Costalos C, Sevastiadou S, et al. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev. 2007;83(9):575-579
77. Tewari VV, Dubey SK, Gupta G. Bacillus clausii for prevention of late-onset sepsis in preterm infants: a randomized controlled trial. J Trop Pediatr. 2015;61(5):377-385
78. Totsu S, Yamasaki C, Terahara M, Uchiyama A, Kusuda S. Bifidobacterium and enteral feeding in preterm infants: cluster-randomized trial. Pediatr Int. 2014;56(5):714-719
79. Saengtawesin V, Tangpolkaiwalsak R, Kanjanapattankul W. Effect of oral probiotics supplementation in the prevention of necrotizing enterocolitis among very low birth weight preterm infants. J Med Assoc Thai. 2014;97(suppl 6):S20-25
80. Ren YF, Wang LL. [Effects of probiotics on intestinal bacterial colonization in premature infants]. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(3):192-194
81. Ren B. Preventive effect of Bifidobacterium tetravaccine tablets in premature infants with necrotizing enterocolitis. J Pediatr Pharm. 2010;16:24-25 [In Chinese]
82. Ke D, Su Z, Li L. Effects of Bifido supplement for prevention of necrotizing enterocolitis in preterm infants: a randomized controlled trial. Chin Pediatr Emerg Med. 2008(12):69-71 [In Chinese]
83. Huang B, Yang H, Huang X. Probiotics supplementation for prevention of necrotizing enterocolitis in very lowbirthweight neonates: a randomized, controlled trial. J Guangdong Med Coll. 2009;27:37-39 [In Chinese]
84. Di M, Li X. Effects of Bifidobacterium supplementation for prevention of necrotizing enterocolitis in pre-term infants: a randomized, controlled trial. Chinese J Commun Doctors. 2010;231:69 [In Chinese]
85. Deng J, Chen K. Early minimal feeding combined with probiotics to prevent necrotizing enterocolitis in preterm infant. Chin J Mod Drug App. 2010;4:13-14 [In Chinese]
86. Yang S, Yi HBG. The clinical application value of endangered preterm infants given earlier amounts of micro feedings and adding probiotics. J Pediatr Pharm. 2011;17:21-24 [In Chinese]
87. Zhou N. [The observation of effect of probiotics in the prevention of neonatal necrotizing enterocolitis]. Chinese J Ethnomed Ethnopharm. 2012;21:81 [In Chinese]
88. Fu H, Song Y. A clinical observation of Bacillus subtilis on neonatal necrotizing enterocolitis. MCH Care of China. 2012;27:2862-2863 [In Chinese]
89. Sadowska-Krawczenko I, Korbal P, Polak A, Wietlicka-Piszcz M, Szajewska H. Lactobacilllus rhamnosus ATC A07FA for preventing necrotizing enterocolitis in very-low-birth weight preterm infants: a randomized controlled trial (preliminary results). [Polish] Pediatr Pol. 2012;87(2):139-145
90. Cooper PA, Bolton KD, Velaphi SC, Pecquet S, Steenhout P. Randomized trial to evaluate effects of Bifidobacterium lactis capsules on incidence of necrotizing enterocolitis in preterm infants. Paper presented at: Pediatric Academic Societies meeting E-PAS 2015:3849. 74; San Diego, CA
91. Indrio F, Riezzo G, Carlucci B, et al. Lactobacillus reuteri DSM 17938 supplementation for modulation of immunity, gastric motility and prevention of feeding intolerance in preterm newborns. Paper presented at: Pediatric Academic Societies meeting E-PAS 2012:1536. 640; Boston, MA
92. Lin HY, Tsai ML, Hung FK, et al. Early oral probiotics and lactoferrin reduces necrotizing enterocolitis and or late onset sepsis for preterm very low birth weight infants. Paper presented at: Pediatric Academic Societies meeting E-PAS 2015:3853. 103; San Diego, CA
93. Coleta E, Gheonea M, Sarbu M. Oral supplementation with probiotics in premature infants: a randomised clinical trial. Intensive Care Med. 2013;39:S113
94. Hu XY, Zhou YX, Xu SZ, Lin YY. Effects of probiotics on feeding intolerance in low birth weight premature infant. Zhongguo Dang Dai Er Ke Za Zhi. 2010;12(9):693-695 [In Chinese]
95. Villar J, Mackey ME, Carroli G, Donner A. Meta-analyses in systematic reviews of randomized controlled trials in perinatal medicine: comparison of fixed and random effects models. Stat Med. 2001;20(23):3635-3647
96. Poole C, Greenland S. Randomeffects meta-analyses are not always conservative. Am J Epidemiol. 1999;150(5):469-475
97. Henmi M, Copas JB. Confidence intervals for random effects metaanalysis and robustness to publication bias. Stat Med. 2010;29(29):2969-2983
98. Schmidt FL, Oh IS, Hayes TL. Fixedversus random-effects models in metaanalysis: model properties and an empirical comparison of differences in results. Br J Math Stat Psychol. 2009;62(pt 1):97-128
99. Deshpande GC, Rao SC, Keil AD, Patole SK. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med. 2011;9:92
100. Deshpande G, Rao S, Patole S. Probiotics in neonatal intensive care: back to the future. Aust N Z J Obstet Gynaecol. 2015;55(3):210-217
101. Deshpande G, Rao S, Patole S, Bulsara M. Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics. 2010;125(5):921-930
102. Härtel C, Pagel J, Rupp J, et al; German Neonatal Network. Prophylactic use of Lactobacillus acidophilus/Bifidobacterium infantis probiotics and outcome in very low birth weight infants. J Pediatr. 2014;165(2):285-289. e1
103. Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit. J Pediatr. 2014;164(5):980-985